Core Viewpoint - Shanghai Haishun New Material Co., Ltd. demonstrates robust growth in 2024, achieving a revenue of 1.143 billion yuan, a year-on-year increase of 11.92%, and a net profit of 74.59 million yuan, showcasing its resilience in a complex market environment through technological innovation and strategic layout [1][2]. Group 1: Pharmaceutical Packaging - The company holds 161 drug packaging material registration numbers and 31 DMF filings, serving renowned pharmaceutical companies such as China National Pharmaceutical Group and AstraZeneca [1]. - Core products include cold-formed composite hard films, PTP aluminum foil, and SP composite films, which are preferred materials for packaging tablets, capsules, and suppositories due to their excellent performance and quality [1]. - The subsidiary Suzhou Haishun has received multiple honors, including being recognized as a five-star cloud enterprise in Jiangsu Province, highlighting its leading position in intelligent production and green manufacturing [1]. Group 2: New Energy Materials - Haishun focuses on the independent research and development of aluminum-plastic film materials, successfully overcoming technical barriers and achieving mass supply to several lithium battery manufacturers [2]. - Aluminum-plastic film is a key material for soft-pack lithium battery packaging, directly affecting battery safety and lifespan [2]. - The company has achieved a net cash flow from operating activities of 161 million yuan in 2024, a significant increase of 60.35% year-on-year, indicating improved operational efficiency and optimized capital management [2]. Group 3: Shareholder Returns and Future Strategy - The board approved a profit distribution plan, proposing a cash dividend of 2.7 yuan per 10 shares (tax included), continuing the tradition of valuing shareholder returns [2]. - The company has repurchased shares amounting to 3% of the total share capital, reflecting management's recognition of the company's long-term value [2]. - Future strategies include deepening the synergistic development of three major sectors: pharmaceutical packaging, new energy, and new consumption, with plans to integrate smart packaging and precise drug delivery technologies in the pharmaceutical sector [2].